Sstyles, Amarin needs the backing of some powerful behind the scenes
player(s.) The Baker Brothers may or may not have given up on this
company. (One rumor I had heard long ago was that they wanted JT to
accept one particular BO offer and JT said No!) If that story is true
perhaps they decided to stop giving advice to JT.
Of course I'm a proponent for a BP BO because it seems stupid to waste
resources building a sales rep network when BP already has done that and
knows how to use them effectively. Imagine where Vascepa sales would
be if AMRN were owned by JNJ,PFE,AZN,Roche, or NVS. The political
power and influence that certain BP wield over our world is amazing.
Does anyone doubt that Pfizer could do a better job selling Vascepa
than GIA Amarin? If the answer is no, then does it not follow that
more CVD patients would benefit if AMRN were in the hands of BP?
Hopefully, JT (and his BOD) understand this and "for legal reasons"
may not disclose their efforts towards a BP BO. The sooner Vascepa
is in BP hands the quicker will be the uptake of Vascepa, especially
in Europe. No BP can seriously believe that JT truly intends to GIA.